335 related articles for article (PubMed ID: 15948171)
1. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
Collins V; Meiser B; Gaff C; St John DJ; Halliday J
Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
[TBL] [Abstract][Full Text] [Related]
2. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations.
Halbert CH; Lynch H; Lynch J; Main D; Kucharski S; Rustgi AK; Lerman C
Arch Intern Med; 2004 Sep; 164(17):1881-7. PubMed ID: 15451763
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
Hadley DW; Jenkins JF; Dimond E; de Carvalho M; Kirsch I; Palmer CG
J Clin Oncol; 2004 Jan; 22(1):39-44. PubMed ID: 14701766
[TBL] [Abstract][Full Text] [Related]
4. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
[TBL] [Abstract][Full Text] [Related]
5. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
[TBL] [Abstract][Full Text] [Related]
6. Surveillance on mutation carriers of DNA mismatch repair genes.
Järvinen HJ; Aarnio M
Ann Chir Gynaecol; 2000; 89(3):207-10. PubMed ID: 11079789
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
[TBL] [Abstract][Full Text] [Related]
8. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
Lerman C; Hughes C; Croyle RT; Main D; Durham C; Snyder C; Bonney A; Lynch JF; Narod SA; Lynch HT
Prev Med; 2000 Jul; 31(1):75-80. PubMed ID: 10896846
[TBL] [Abstract][Full Text] [Related]
10. Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome.
Hadley DW; Jenkins JF; Steinberg SM; Liewehr D; Moller S; Martin JC; Calzone KA; Soballe PW; Kirsch IR
J Clin Oncol; 2008 Feb; 26(6):948-54. PubMed ID: 18281669
[TBL] [Abstract][Full Text] [Related]
11. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
McCann S; MacAuley D; Barnett Y; Bunting B; Bradley A; Jeffers L; Morrison PJ
Psychooncology; 2009 Nov; 18(11):1208-15. PubMed ID: 19177338
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
Bernstein IT; Bisgaard ML; Myrhøj T
Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
[TBL] [Abstract][Full Text] [Related]
13. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
Meiser B; Collins V; Warren R; Gaff C; St John DJ; Young MA; Harrop K; Brown J; Halliday J
Clin Genet; 2004 Dec; 66(6):502-11. PubMed ID: 15521977
[TBL] [Abstract][Full Text] [Related]
14. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
[TBL] [Abstract][Full Text] [Related]
15. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test.
Claes E; Denayer L; Evers-Kiebooms G; Boogaerts A; Philippe K; Tejpar S; Devriendt K; Legius E
Genet Test; 2005; 9(1):54-65. PubMed ID: 15857188
[TBL] [Abstract][Full Text] [Related]
16. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
Brown GJ; St John DJ; Macrae FA; Aittomäki K
Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
[TBL] [Abstract][Full Text] [Related]
17. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
[TBL] [Abstract][Full Text] [Related]
18. Attitudes toward colon cancer gene testing: factors predicting test uptake.
Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
[TBL] [Abstract][Full Text] [Related]
19. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
20. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
